Acute and chronic cystitis and pyelonephritis; treatment of urolithiasis; prevention of urolithiasis; biliary dyskinesia, cholelithiasis; chronic calculous and non-calculous cholecystitis.
Composition and form of release
One capsule contains a thick extract of urolesan 10% – 10.7 mg in terms of moisture (dry residue: hop cones – 6.33 mg, wild fruit carrots – 1.84 mg, oregano herb – 1.46 mg), pepper oils mint – 7.46 mg, fir oils – 25.50 mg.
auxiliary ingredients: polysorbate-80, citric acid, sorbic acid, sugar syrup, purified water, disodium edetate.
Urolesan is a combined herbal medicine. The components of the drug help to reduce inflammation in the kidneys, urinary tract, increase blood circulation in the kidneys, liver, exhibit diuretic (diuretic), choleretic, antibacterial effects, form a protective colloid in the urine, and also normalize the tone of smooth muscle fibers of the upper urinary tract, gallbladder. The drug causes an increase in the release of chlorides, urea, promotes the excretion of small calculi (stones), sand from the bladder, kidneys. The components of the drug are well absorbed, its action begins within 30 minutes after ingestion, and lasts for 5 hours. The maximum medicinal effect occurs after 1 hour. The drug is excreted through the digestive tract, as well as by the kidneys.
It is prescribed for acute / chronic infections of the kidneys, urinary tract (cystitis, pyelonephritis). Urolesan is also indicated for urolithiasis (urolithiasis), uric acid diathesis. It can be used as a medication that prevents the formation of urinary stones (in the presence of risk factors, after removal of urinary stones).
It can be prescribed for the chronic form of cholecystitis (including with the presence of stones – calculous), biliary dyskinesia, cholelithiasis (cholelithiasis).
Urolesan is not prescribed in case of hypersensitivity to the components of this drug (which in the past have already observed allergic reactivity to any of the components of this drug), allergies to plants of the Hemp family, plants of the Umbrella family, plants of the Lamb family, hyperacid stomach inflammation (gastritis with high acidity) , peptic ulcer, erosive lesions of the stomach, 12-duodenum. Do not use the drug in case of large stones (3 mm).
Care should be taken when prescribing Urolesan in the form of a syrup to people with diabetes mellitus, as well as to patients with high blood sugar (sugar syrup is present in the drug). Caution during use is also needed in patients with bronchial asthma due to the risk of developing bronchospasm (a sharp narrowing of the bronchi). Children under the age of 14 are prescribed a drug in liquid form (syrup or solution). The drug in the form of a syrup cannot be administered to children under two years of age. If necessary, use in children under seven years of age, Urolesan syrup is used.
Application during pregnancy and lactation
The appointment of this pharmacological agent during pregnancy, breastfeeding has not been studied, therefore, the use is contraindicated.
Method of administration and dosage
The drug Urolesan should be taken orally before meals. A single dose, frequency of administration, duration of the course of treatment is determined by the doctor.
Dosage of capsules: the recommended dose for adults and children over the age of 14 is 1 capsule x 3 times / day. In acute conditions (including renal / hepatic colic), the duration of the course of treatment is 5–7 days, in chronic conditions – from seven days to a month. In the event of renal / hepatic colic, a single dose is allowed to be increased once to two capsules, and in subsequent doses, return to the standard single dose (one capsule).
Signs of an overdose with Urolesan: possible vomiting, dizziness.
Overdose treatment: plentiful warm drink, intake of enterosorbent (activated carbon), rest, appointment of atropine sulfate (0.5-1 mg).
Disorders from the digestive system: dyspeptic symptoms (heartburn, nausea, belching);
Disorders from the immune system: allergic manifestations in the form of itching, facial redness, skin rashes, angioedema (sore throat, shortness of breath, swelling of parts of the face, tongue), anaphylactic shock (severe itching of the skin, quickly spreading over the skin, sharp drop in blood pressure, vomiting, loose stools, laryngeal edema, noisy and labored breathing, pallor or cyanosis of the skin, a sharp narrowing of the bronchi and larynx, leading to acute difficulty in breathing, loss of consciousness, disorder of the vital organs);
Disorders from the central / peripheral nervous system: general weakness, dizziness, ataxia (impaired coordination of movements), headache, muscle tremor;
Disorders from the cardiovascular system: arterial hypotension / hypertension, bradycardia (slow heartbeat), pain in the heart.
Storage conditions and periods
Capsules should be stored in their original (factory) packaging, subject to temperature conditions (within 15-25 ° C), low humidity and no direct sunlight. The maximum shelf life differs for dosage forms (indicated on the package). Parents need to keep their children safe and restrict their access to medication.